Price Alert

Kairos Pharma Ltd. (KAPA)

AMEX: KAPA · Real-Time Price · USD

1.19

-0.05 (-4.03%)

At close: Aug 15, 2025, 3:59 PM

1.22

2.68%

After-hours: Aug 15, 2025, 07:54 PM EDT

Kairos Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-2.6M	-1.81M	-1.05M	-2.15M
Depreciation & Amortization	160K	160K	160K	98K
Stock-Based Compensation	218K	913K	n/a	300K
Other Working Capital	-1.98M	764K	129K	1.19M
Other Non-Cash Items	254K	56K	408K	144K
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	-1.98M	764K	129K	1.19M
Operating Cash Flow	-3.96M	81K	-353K	-412K
Capital Expenditures	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	-109K
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	-109K
Debt Repayment	n/a	n/a	895K	330K
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	-390K	n/a	-121K	n/a
Financial Cash Flow	5.13M	-425K	717K	580K
Net Cash Flow	1.18M	-344K	364K	59K
Free Cash Flow	-3.96M	81K	-353K	-412K